TECHWIRE 30
(CIX: WRAL30)  1,085.92  up arrow+9.26  (0.86 %)  Updated: 08:10 PM EDT, Oct 24 2014
(NQ: Apple)  105.22  up arrow+0.39  (0.37 %)  Updated: 08:10 PM EDT, Oct 24 2014
(NY: QUINTILES)  57.56  up arrow+0.57  (1 %)  Updated: 06:40 PM EDT, Oct 24 2014
(OP: BASF SE)  87.22  down arrow-2.43  (-2.71 %)  Updated: 08:10 PM EDT, Oct 24 2014
(NQ: BioCryst)  11.83  down arrow-0.36  (-2.95 %)  Updated: 08:10 PM EDT, Oct 24 2014
(NQ: BioDelivery)  16.62  up arrow+0.24  (1.47 %)  Updated: 08:10 PM EDT, Oct 24 2014
(NQ: CEMP)  12.46  up arrow+0.14  (1.14 %)  Updated: 08:10 PM EDT, Oct 24 2014
(NQ: Cisco Systems)  23.78  up arrow+0.22  (0.91 %)  Updated: 08:10 PM EDT, Oct 24 2014
(NQ: Cree)  29.67  up arrow+0.27  (0.92 %)  Updated: 08:10 PM EDT, Oct 24 2014
(NQ: DARA)  0.87  down arrow-0.03  (-3.34 %)  Updated: 08:10 PM EDT, Oct 24 2014
(NY: EMC CORPORATION)  28.17  up arrow+0.47  (1.7 %)  Updated: 06:40 PM EDT, Oct 24 2014
(NQ: Extreme Networks)  3.14  up arrow+0.02  (0.64 %)  Updated: 08:10 PM EDT, Oct 24 2014
(NQ: FB)  80.67  up arrow+0.63  (0.79 %)  Updated: 08:10 PM EDT, Oct 24 2014
(NY: GLAXOSMITHKLINE)  45.79  up arrow+0.43  (0.95 %)  Updated: 06:40 PM EDT, Oct 24 2014
(NQ: GOOG)  539.78  down arrow-4.2  (-0.77 %)  Updated: 08:10 PM EDT, Oct 24 2014
(NY: IBM)  162.08  down arrow-0.1  (-0.06 %)  Updated: 06:40 PM EDT, Oct 24 2014
(NY: LH)  103.73  up arrow+1.05  (1.02 %)  Updated: 06:40 PM EDT, Oct 24 2014
(OP: Lenovo Group)  29.09  up arrow+0.07  (0.24 %)  Updated: 08:10 PM EDT, Oct 24 2014
(NY: MRK)  57.61  up arrow+0.98  (1.73 %)  Updated: 06:40 PM EDT, Oct 24 2014
(NQ: Microsoft Corp)  46.13  up arrow+1.11  (2.47 %)  Updated: 08:10 PM EDT, Oct 24 2014
(NQ: NTAP)  40.72  up arrow+0.42  (1.04 %)  Updated: 08:10 PM EDT, Oct 24 2014
(NY: NOVARTIS AG)  90.15  up arrow+0.91  (1.02 %)  Updated: 06:40 PM EDT, Oct 24 2014
(OP: Novozymes A/S)  44.71  up arrow+0.17  (0.38 %)  Updated: 08:10 PM EDT, Oct 24 2014
(NY: PFIZER)  29.11  up arrow+0.51  (1.78 %)  Updated: 06:40 PM EDT, Oct 24 2014
(NQ: Pozen)  8.75    (0 %)  Updated: 08:10 PM EDT, Oct 24 2014
(NY: RED HAT)  56.02  up arrow+0.51  (0.92 %)  Updated: 06:40 PM EDT, Oct 24 2014
(NQ: BBRY)  10.26  down arrow-0.06  (-0.53 %)  Updated: 08:10 PM EDT, Oct 24 2014
(NQ: Salix)  140.42  up arrow+4.86  (3.59 %)  Updated: 08:10 PM EDT, Oct 24 2014
(NQ: SQI)  15.60  up arrow+0.08  (0.52 %)  Updated: 08:10 PM EDT, Oct 24 2014

Posts tagged “Metabolon”

May 13

Premium Lock GSK to utilize genomics data, services from Metabolon

Triangle-based Metabolon, which recently struck a deal with DNA pioneer Craig Venter to help us find ways to live longer, has another high-profile partner: GlaxoSmithKline. The two neighbors disclosed a new collaboration agreement Tuesday.

Metabolon’s “Analytical Platform”: Metabolon’s “Analytical Platform”:

Updated March 6

Premium Lock Genome pioneer Craig Venter launches DNA firm aiming to help us all live to be 100

J. Craig Venter, the man who raced the U.S. government to sequence the first human genome, has a new goal: Help everyone live to 100, in good health. And one of his first partners is RTP-based Metabolon, where he serves as a scientific adviser.

A sample of testing done at Craig Venter's new firm A sample of testing done at Craig Venter's new firm

Updated March 6

Premium Lock RTP's Metabolon to help genome pioneer Craig Venter find ways to help us live longer

Metabolon will utilize its proprietary molecular technology to help Human Longevity Inc., the new company led by genome pioneer Craig Venter, to find indications of disease and gene mutations.

Mapping the genome Mapping the genome

Updated March 5

Premium Lock Raleigh M2M firm sold; Metabolon's new deal; Red Hat expands 'cloud;' FDA nod for OxyBio; Pozen cuts losses; reboot costs TransEnterix

Bulldog In today's Bullbog blog rounding up the latest tech and life science news: Raleigh-based Jazz Wireless is sold; Metabolon makes a deal with Craig Venter firm; Red Hat joins AWS GovCloud; Oxygen Biotherapeutics can advance research on brain treatment; Pozen cuts its losses; and TransEnterix losses mount as company reboots.

Updated January 6

Premium Lock Two new investors help Metabolon raise $15M

Metabolon, whose proprietary technology has applications in medical diagnostics as well as food and nutrition, is getting a financial boost from two new investors as well as six existing ones in its new round of funding.

Metabolon’s “Analytical Platform”: Metabolon’s “Analytical Platform”:

Updated December 31, 2013

Premium Lock Metabolomics company Metabolon raises $15M

Metabolon Metabolon, whose proprietary technology has applications in medical diagnostics as well as food and nutrition, launched the $15 million equity financing round on Dec. 16.

Updated November 4, 2013

Premium Lock Startup Brevado keeps businesses, clients on same page

Startup Brevado was running out of money when an advisor gave the team one week to remake the business. Read how they did it and made it to a launch today.

Brevado, laptop Brevado, laptop

Updated November 4, 2013

Premium Lock Metabolon: Bloodhound of biotech on trail of success

Metabolon is the bloodhound of biotech and the 13-Research Triangle Park company is poised to take home a lot more bones from sales of its hot products, writes the N.C. Biotech Center's Jim Shamp.

Metabolon’s “Analytical Platform”: Metabolon’s “Analytical Platform”:

October 30, 2013

Premium Lock Metabolon lands marketing partner for prostate cancer test

Metabolon's Prostarix will be marketed by Bostwick Laboratories, giving Metabolon access to one of the largest urology networks in the country.

Metabolon’s “Analytical Platform”: Metabolon’s “Analytical Platform”:

Updated August 28, 2013

Premium Lock DHMRI, Metabolon partner on nutrition research

David Murdock Food and nutrition research at the David H. Murdock Research Institute is getting a boost through a new partnership with Research Triangle Park metabolomics company Metabolon.

August 28, 2013

Premium Lock Murdock Research Institute, Metabolon partner for biochemical tests

Food and nutrition research at the David H. Murdock Research Institute is getting a boost through a new partnership with Research Triangle Park metabolomics company Metabolon.

Metabolon’s “Analytical Platform”: Metabolon’s “Analytical Platform”:

August 21, 2013

Premium Lock Metabolon settles patent dispute with Wisconsin firm

Metabolon The RTP-based diagnostic technology firm strikes a licensing deal with Stemina Biomarker Discovery a year after it filed suit.

July 9, 2013

Premium Lock Metabolon, IMDEA Food partner to find molecular links between food and disease

Food research Metabolon is partnering with a Spain-based research institute to develop new food and diagnostic tools based on better understanding how food affects health at the molecular level.

June 21, 2013

Premium Lock Metabolon diabetes test gives earlier, more accurate info, study says

Metabolon Metabolon says its diabetes test gives earlier and more accurate information about the likelihood for developing diabetes compared to traditional tests. Read more about Metabolon's Quantose test.

Updated June 17, 2013

Premium Lock Human genes can't be patented, but biotechs have already shifted strategy

Even before the U.S. Supreme Court decision disallowed human gene patents, biotechnology companies shifted their strategies. Learn how biotechs adjusted.

DNA    DNA

December 5, 2012

Premium Lock RTP genomics firm Metabolon lands deal renewal with Syngenta

New crop research facility coming to N.C. Metabolon and Syngenta have renewed an agreement through which Metabolon provides biochemical profiling technology to the agribusiness giant.

December 3, 2012

Premium Lock RTP firm Metabolon helps set pace in improved diagnostic medical testing

Companies specializing in innovative diagnostics are likely not only to find financial success, but to improve the way health care is delivered to patients. Metabolon is among the merging leaders.

Metabolon’s “Analytical Platform”: Metabolon’s “Analytical Platform”:

September 10, 2012

Premium Lock NC Biotech Center's Industrial Fellowship Program leads to new careers

The North Carolina Biotechnology Center's Industrial Fellowship Program provides opportunities for Ph.D. scientists from the state's many prestigious universities to gain valuable industry-based experience. Metabolon's Meredith Brown is proof.

Meredith Brown Meredith Brown

August 29, 2012

Premium Lock RTP-based Metabolon sues rival biomarker firm

Metabolon Stemina Biomarker Discovery Inc. is accused of infringing two patents that cover methods of drug discovery, disease treatment and diagnosis using the study of the chemical processes of metabolites.

Techwire Inside Partners
The Skinny: A Blog by Rick Smith

OUR INSIDERS

Dr. Mike Walden
Tech economy
Vivek Wadhwa
Commentary
Frank Vinluan
Life science
Scroll